p. 271-286
Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+-ATPase subunits
Yun Lin, Dah H. Ho, Robert A. Newman
Abstract
Full Text (IP)
p. 287-295
Zinc functions as a cytotoxic agent for prostate cancer cells independent of culture and growth conditions
Christopher L. Kriedt, Joseph Baldassare, Maulik Shah and Claudette Klein
Abstract
Full Text (IP)
p. 297-312
Altered down regulation of the receptor tyrosine kinase Met in pancreatic adenocarcinoma cells
Kristen S. Hill, Marta Lorinczi and Lisa A. Elferink
Abstract
Full Text (IP)
p. 313-319
Prospective study of second-line chemotherapy for non-small cell lung cancer selected according to EGFR gene status
Fumihiro Oshita, Yohei Miyagi, Takeshi Honda, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Kazumasa Noda, Tomoyuki Yokose, Yoichi Kameda, Yuji Sakuma, Masato Obata and Kouzo Yamada
Abstract
Full Text (IP)
p. 321-325
A patient with metastatic colon cancer to the liver presenting with cardiac arrest status post receiving combination Irinotecan-Panitumumab: a case report
Bassem Mohammad Toema
Abstract
Full Text (IP)
p. 327-339
NEROFE™ – A novel human hormone-peptide with anti-cancer activity
Uziel Sandler, Orly Devary, Ori Braitbard, Joel Ohana, Gideon Kass, Ariel M. Rubinstein, Zeev Y. Friedman and Yoram Devary
Abstract
Full Text (IP)
p. 341-352
Biomarkers for the diagnosis of thyroid cancer
Kruttibas Sethi, Siddik Sarkar, Subhasis Das, Biswanarayan Mohanty and Mahitosh Mandal
Abstract
Full Text (IP)